Jeffrey L. Ives's Net Worth
$837 Thousand
Who is Jeffrey L. Ives?
Jeffrey L. Ives does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Cara Therapeutics, Inc., and Acumen Pharmaceuticals, Inc..
SEC CIK
Jeffrey L. Ives's CIK is 0001614096
Past Insider Trading and Trends
2020 was Jeffrey L. Ives's most active year for acquiring shares with 9 total transactions. Jeffrey L. Ives's most active month to acquire stocks was the month of May. 2020 was Jeffrey L. Ives's most active year for disposing of shares, totalling 13 transactions. Jeffrey L. Ives's most active month to dispose stocks was the month of July. 2020 saw Jeffrey L. Ives paying a total of $173,562.50 for 34,000 shares, this is the most they've acquired in one year. In 2023 Jeffrey L. Ives cashed out on 83,898 shares for a total of $272,333.52, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Cara Therapeutics, Inc. (CARA) Snapshot price: $0.3227
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +314.91% | 150.65K |
—
|
—
| 198.49K |
Jun 4
| |||
Form 4
| +209.11% | 32.36K |
—
|
—
| 47.84K |
Jun 1
| |||
Form 4
| -18.87% | -3.60K |
$9.05 | -$32,580.00 | 15.48K |
Scheduled
|
Jul 15
| ||
Form 4
| +164.94% | 11.88K |
—
|
—
| 19.08K |
Jun 2
| |||
Form 4
| -53.19% | -8.18K |
$16.04 | -$131,207.20 | 7.2K |
Nov 12
| |||
Form 4
| +43.74% | 4.68K |
$13.05 | -$32,886.00 | 15.38K |
Scheduled
|
Jun 3 - Jun 7
| ||
Form 4/A
| -18.94% | -2.50K |
$15.75 | -$39,372.50 | 10.7K |
Nov 19
| |||
Form 4
| +30.49% | 2.5K |
$15.75 | $39,372.50 | 10.7K |
Nov 19
| |||
Form 4
| +120.00% | 7.2K |
—
|
—
| 13.2K |
Jun 4
| |||
Form 4
|
—
|
0
|
$12.97 | -$6,060.00 | 6K |
Scheduled
|
Jun 1
| ||
Form 4
|
—
|
0
|
$12.97 | -$15,150.00 | 6K |
Scheduled
|
May 12
| ||
Form 4
|
—
|
0
|
$12.97 | -$15,150.00 | 6K |
Scheduled
|
Apr 21
| ||
Form 4
|
—
|
0
|
$12.97 | -$15,150.00 | 6K |
Scheduled
|
Mar 4
| ||
Form 4
|
—
|
0
|
$13.09 | -$15,725.00 | 6K |
Scheduled
|
Feb 3
| ||
Form 4
|
—
|
0
|
$13.04 | -$15,475.00 | 6K |
Scheduled
|
Jan 2
| ||
Form 4
|
—
|
0
|
$15.58 | -$51,275.00 | 6K |
Scheduled
|
Dec 2
| ||
Form 4
|
—
|
0
|
$13.00 | -$38,400.00 | 6K |
Scheduled
|
Nov 1
| ||
Form 4
|
—
|
0
|
$11.77 | -$32,225.00 | 6K |
Scheduled
|
Oct 1
| ||
Form 4
|
—
|
0
|
$14.32 | -$44,975.00 | 6K |
Scheduled
|
Sep 3
| ||
Form 4
|
—
|
0
|
$14.28 | -$44,800.00 | 6K |
Scheduled
|
Aug 1
| ||
Form 4
|
—
|
0
|
$13.54 | -$41,075.00 | 6K |
Scheduled
|
Jul 1
| ||
Form 4
|
∞
| 6K |
—
|
—
| 6K |
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Acumen Pharmaceuticals, Inc. (ABOS) Snapshot price: $2.18
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
$3.62 | -$240,814.24 |
0
|
Aug 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||